Adam Sragovicz - Dec 1, 2023 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Role
Chief Financial Officer
Signature
/s/ Adam Sragovicz
Stock symbol
CDT
Transactions as of
Dec 1, 2023
Transactions value $
$0
Form type
4
Date filed
12/5/2023, 05:20 PM
Previous filing
Jan 4, 2023
Next filing
May 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDT Restricted Stock Units Award +74.5K 74.5K Dec 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted with a vesting schedule of 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.